News & Insights
Besides sharing our hands-on expertise in projects, we regularly share industry insights, updates, and news. At NecstGen, we believe in sharing best practices to advance patient health. Together.
Sander van Deventer joins strategic advisory board of NecstGen
NECSTGEN announces the appointment of Sander van Deventer to its strategic advisory board. Sander van Deventer adds both scientific as well as commercial expertise in the field of cell and gene therapy. He is professor of Translational gastroenterology at the Leiden...
NecstGen Teams up with IT-partner LINKIT
NECSTGEN has started a collaboration with IT-partner LINKIT. NECSTGEN is a spin out of the Leiden University Medical Center that will support clinicians, academic groups and small industrial therapy developers globally to bring cell and gene therapies to patients....
Launch of NecstGen in Leiden, The Netherlands
We are happy to announce the official launch of the Netherlands Center for the Clinical Advancement of Stem Cell & Gene Therapies (NECSTGEN). The new center has been established to accelerate the development and clinical realization of cell and gene therapies....